Pharmabiz1d
SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis
SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis: Beijing Thursday, March 27, 2025, 15:0 ...
BioWorld3d
Sineugene’s TRIM72-targeted gene therapy for ALS gains IND clearance from FDA
Sineugene Therapeutics Co. Ltd. has obtained IND clearance from the FDA for SNUG-01, a first-in-class tripartite motif ...
Nature1y
Paxillin LD motifs may define a new family of protein recognition domains
Cells assemble protein networks through regions of protein recognition that are found in numerous proteins as conserved peptide motifs. This allows for the specific and efficient communication of ...
Nature3mon
A curated compendium of phosphorylation motifs
Until now, however, there has been no single resource that allows investigators to determine whether a protein/peptide of interest contains a motif that has been previously described in the ...
Hosted on MSN5mon
Exploring the role of chemokines in atrial fibrillation development
Chemokines are a subclass of cytokines, a large family of small secreted proteins that communicate ... persistent AF have higher levels of C-X-C motif chemokine ligand 8 (CXCL8) than those with ...